Who invested in Context Therapeutics?
Context Therapeutics's investors include Blackstone Group and Blue Owl.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$100Mraised across 1 round since 2024, from 1 source
From Context Therapeutics's own website and the SEC filings it signed: 8 on the team.
On the board, as filediJennifer Beth Evans StaceyPhilip Jay KantoffRichard Jay Berman
Context Therapeutics's investors include Blackstone Group and Blue Owl.
Context Therapeutics has raised $100M across 1 round since 2024.
Context Therapeutics's most recent round was an Undisclosed round of $100M in May 2024.
Its most recent round, $100M in May 2024, is also its largest on record.
Context Therapeutics's first round on record, in May 2024, was backed by Blackstone Group and Blue Owl.
Context Therapeutics's latest named round is an Undisclosed round, in May 2024.
Context Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.